Beijing Beilu Pharmaceutical (300016.SZ) Earnings Analysis
Beijing Beilu Pharmaceutical (300016.SZ) has no confirmed upcoming earnings date. Trailing P/E 34.41.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300016.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 300016.SZ. This page updates as the calendar is published.
300016.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.0863 CNY | n/a | n/a | n/a |
| 2025-10-29 | 0.02649 CNY | n/a | n/a | n/a |
| 2025-04-25 | 0.02955 CNY | n/a | n/a | n/a |
| 2025-04-17 | -0.02361 CNY | n/a | n/a | n/a |
| 2024-09-29 | 0.00987 CNY | n/a | n/a | n/a |
300016.SZ valuation and analyst view
| Trailing P/E | 34.41 |
|---|---|
| Trailing EPS | 0.21909 CNY |
| Price / book | 1.88 |
| Dividend yield | 0.00% |
| Market cap | 4.40B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Beijing Beilu Pharmaceutical (300016.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 300016.SZ. This page updates as the calendar is published.
Did 300016.SZ beat earnings last quarter?
Consensus estimate data was not available for 300016.SZ's 2026-04-22 report.
What is 300016.SZ's current P/E ratio and EPS?
300016.SZ trades at a trailing P/E of 34.41 on trailing EPS of 0.2190902355150705 CNY.
What do analysts rate 300016.SZ?
300016.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.